Larimar Therapeutics (LRMR) Q3 2026 Earnings

6AugConfirmed
Q3 2025
Q4 2025
Q2 2026
Next
-0.61
-0.51
-0.41
-0.31

Details

Expected EPS
-0.399911
Actual EPS
N/A
Surprise EPS
0.4
Surprise Percent
+100%

Description

Larimar Therapeutics (LRMR) will report earnings of for Q3 2026 on August 06, 2026.

0 Comments

Share your thoughts